206,482 421,941 423,003
Non-GAAP operating
expenses 3,491,735 3,008,184 7,232,329 5,757,185
Operating (Loss) Gain
GAAP operating
loss (591,619) (1,384,992) (1,049,207) (2,194,339)
SFAS 123 (R)
share-based
compensation 207,010 503,556 490,001 670,642
Depreciation
expenses 75,161 59,433 145,008 106,763
Amortization
expenses 210,966 206,482 421,941 423,003
Non-GAAP
operating (loss)
gain (98,482) $(615,521) 7,743 $(993,931)
'/>"/>SOURCE Uroplasty, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine news :1.
Uroplasty to Present at the Noble Financial Fourth Annual Equity Conference2.
Uroplasty to Host First Quarter Conference Call on July 313.
Uroplasty Joins the Russell Microcap Index4.
Uroplasty Reports Record Growth for the Fourth Quarter and Fiscal Year 20085.
Uroplasty to Host Fourth Quarter and Year End Conference Call on June 36.
Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting7.
Uroplasty Plans to Double Sales Force During Fiscal 20098.
Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium9.
Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference10.
Uroplasty Expands Marketing Program for Urology Practices11.
Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock